Lack of association between ACE and bradykinin B2 receptor gene polymorphisms and ACE inhibitor-induced coughing in hypertensive Koreans

Journal of Clinical Pharmacy and Therapeutics

Volumn 34, Issue 5, 2009, Pages 561-567

  Woo, S W ^a   Bang, S ^a   Chung, M W ^a   Jin, S K ^a   Kim, Y S ^b   Lee, S H ^c  

^a National Institute of Toxicological Research   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Korea University College of Medicine   (South Korea)

Author keywords

ACE gene; Angiotensin converting enzyme inhibitors; Bradykinin B2 receptor gene; Coughing; Single nucleotide polymorphism

Indexed keywords

BRADYKININ B2 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; ASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; EXON; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENOTYPE; HUMAN; HYPERTENSION; INDEL MUTATION; INTRON; MALE; PROMOTER REGION; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASIAN CONTINENTAL ANCESTRY GROUP; COUGH; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, BRADYKININ B2;

EID: 70049083398     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2009.01028.x     Document Type: Article

References (23)

1. Nonoguchi H, Kiyama S, Inoue H et al. (2003) Angiotensin-converting enzyme inhibitor withdrawal and ACE gene polymorphism. Clinical Nephrology, 60, 225 232.
2. Ding PY, Hu OY, Pool PE, Liao W (2000) Does Chinese ethnicity affect the pharmacokinetics and pharmacodynamics of angiotensin-converting enzyme inhibitors. Journal of Human Hypertension, 14, 163 170.
3. Elliott WJ (1996) Higher incidence of discontinuation of angiotensin converting enzyme inhibitors due to cough in black subjects. Clinical Pharmacology and Therapeutics, 60, 582 588.
4. Mukae S, Aoki S, Itoh S, Iwata T, Ueda H, Katagiri T (2000) Bradykinin B(2) receptor gene polymorphism is associated with angiotensin-converting enzyme inhibitor-related cough. Hypertension, 36, 127 131.
5. Schelleman H, Klungel OH, Van Duijn CM, Witteman JC, Hofman A, De Boer A, Stricker BH (2006) Drug-gene interaction between the insertion/deletion polymorphis of the angiotensin-converting enzyme gene and antihypertensive therapy. Annals of Pharmacotherapy, 40, 212 218.
6. Castellano M, Glorioso N, Cusi D et al. (2003) Genetic polymorphism of the renin-angiotensin-aldosterone system and arterial hypertension in the Italian population: the GENIPER Project. Journal of Hypertension, 21, 1853 1860.
7. Kawakami Y, Munakata M, Yamaguchi E, Furuya K, Matsuda T (1998) Molecular studies of bronchial asthma, sarcoidosis and angiotensin converting enzyme inhibitor-induced cough. Respirology, 3, 45 49.
8. Lee EJ (1994) Population genetics of the angiotensin-converting enzyme in Chinese. British journal of clinical pharmacology, 37, 212 214.
9. Scharplatz M, Puhan MA, Steurer J, Bachmann LM (2004) What is the impact of the ACE gene insertion/deletion (I/D) polymorphism on the clinical effectiveness and adverse events of ACE inhibitors? Protocol of a systematic review. BMC Medical Genetics, 5, 23.
10. Niu T, Chen X, Xu X (2002) Angiotensin converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: therapeutic implications. Drugs, 62, 977 993.
11. Mattace-Raso FU, Sie MP, Van der Cammen TJ, Safar ME, Hofman A, Van Duijn CM, Witteman JC (2007) Insertion/deletion gene polymorphism of the angiotensin-converting enzyme and blood pressure changes in older adults. The Rotterdam study. Journal of Human Hypertension, 21, 736 740. (Pubitemid 47335304)
12. Lee YJ, Tsai JC (2001) Angiotensin-converting enzyme gene insertion/deletion, not bradykinin B2 receptor -58T/C gene polymorphism, associated with angiotensin-converting enzyme inhibitor-related cough in Chinese female patients with non-insulin-dependent diabetes mellitus. Metabolism, 50, 1346 1350.
13. Mukae S, Aoki S, Itoh S, Sato R, Nishio K, Iwata T, Katagiri T (2003) Mitochondrial 5178A/C genotype is associated with acute myocardial infarction. Circulation Journal, 67, 16 20.
14. Yeo WW, Ramsay LE, Morice AH (1991) ACE inhibitor cough: a genetic link? Lancet, 337, 187.
15. Zee RY, Rao VS, Paster RZ, Sweet CS, Lindpaintner K (1998) Three candidate genes and angiotensin-converting enzyme inhibitor-related cough: a pharmacogenetic analysis. Hypertension, 31, 925 928.
16. Marsh S, McLeod HL (2006) Pharmacogenomics: from bedside to clinical practice. Human Molecular Genetics, 15 (Spec No 1 R89 R93.
17. Furuya K, Yamaguchi E, Hirabayashi T, Itoh A, Hizawa N, Ohnuma N, Kawa-kami Y (1994) Angiotensin-I-converting enzyme gene polymorphism and susceptibility to cough. Lancet, 343, 354.
18. Okumura H, Nishimura E, Kariya S et al. (2001) No relation between angiotensin-converting enzyme (ACE) inhibitor-induced cough and ACE gene polymorphism, plasma bradykinin, substance P and ACE inhibitor concentration in Japanese patients. Yakugaku Zasshi, 121, 253 257.
19. Lu J, Li L.M, Zhan SY, Yang HY, Li XH, Cao WH, Hu YH (2003) Study on candidate genes of benazepril related cough in Chinese hypertensives. Zhonghua Liu Xing Bing Xue Za Zhi, 24, 498 502.
20. Rotimi C, Puras A, Cooper R et al. (1996) Polymorphisms of renin-angiotensin genes among Nigerians, Jamaicans, and African Americans. Hypertension, 27, 558 563.
21. Takahashi T, Yamaguchi E, Furuya K, Kawakami Y (2001) The ACE gene polymorphism and cough threshold for capsaicin after cilazapril usage. Respiratory Medicine, 95, 130 135.
22. Tamaki S, Nakamura Y, Tsujita Y et al. (2002) Polymorphism of the angiotensin converting enzyme gene and blood pressure in a Japanese general population (the Shigaraki Study). Hypertension Research, 25, 843 848.
23. Braun A, Kammerer S, Maier E, Bohme E, Roscher AA (1996) Polymorphisms in the gene for the human B2-bradykinin receptor. New tools in assessing a genetic risk for bradykinin-associated diseases. Immunopharmacology, 33, 32 35.